| ［1］ |
Parrish RH 2nd, Findley R, Elias KM, et al. Pharmacotherapeutic prophylaxis and post⁃operative outcomes within an Enhanced Recovery After Surgery（ERAS®） program: a randomized retrospective cohort study［J］. Ann Med Surg（Lond）, 2022,73:103178. doi: 10.1016/j.amsu.2021.103178.
|
| ［2］ |
Schmitt A, DePry J, Tsai S, et al. Retrospective evaluation of the safety of large skin flap, large skin graft, and interpolation flap surgery in the outpatient setting［J］. Dermatol Surg, 2018,44（12）:1537⁃1546. doi: 10.1097/DSS.0000000000001605.
|
| ［3］ |
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence⁃Based Clinical Practice Guidelines［J］. Chest, 2012,141（2 Suppl）:e227S⁃e277S. doi: 10.1378/chest.11⁃2297.
|
| ［4］ |
Gajebasia S, Kerr R, Affleck A. Preoperative management of blood thinning agents during cutaneous surgery: the need for an individualized approach［J］. J Am Acad Dermatol, 2021,84（1）:e41⁃e42. doi: 10.1016/j.jaad.2020.08.075.
|
| ［5］ |
Redi U, Marruzzo G, Codolini L, et al. Venous thromboembolism prophylaxis in plastic surgery: state of the art and our approach［J］. Eur Rev Med Pharmacol Sci, 2021,25（21）:6603⁃6612. doi: 10.26355/eurrev_202111_27103.
|
| ［6］ |
Denzinger M, Held M, Amr A, et al. The influence of topically administered heparin on peripheral microcirculation of the skin: a double⁃blind, randomized, controlled preliminary study on 50 healthy subjects［J］. J Reconstr Microsurg, 2021,37（8）:694⁃703. doi: 10.1055/s⁃0041⁃1726028.
|
| ［7］ |
Taylor O, Carr C, Greif C, et al. Postoperative bleeding complications associated with blood thinning agents during Mohs micrographic surgery: a retrospective cohort study［J］. J Am Acad Dermatol, 2021,84（1）:225⁃227. doi: 10.1016/j.jaad.2020. 06.011.
|
| ［8］ |
Jørgensen L, Matzen RD, Albertsdottir E, et al. Complications in skin grafts when continuing antithrombotic therapy prior to cutaneous surgery requiring skin grafting: an observational study［J］. J Plast Surg Hand Surg, 2020,54（6）:352⁃357. doi: 10.1080/2000656X.2020.1781141.
|
| ［9］ |
Muzumdar S, Feng H. Application of cyanoacrylate to achieve hemostasis in elderly patients with inflamed, friable, and fragile skin receiving anticoagulation therapy after dermatologic surgery［J］. J Am Acad Dermatol, 2020,83（2）:e97. doi: 10.1016/j.jaad. 2019.10.062.
|
| ［10］ |
Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence⁃Based Clinical Practice Guidelines［J］. Chest, 2012,141（2 Suppl）:e326S⁃e350S. doi: 10.1378/chest.11⁃2298.
|
| ［11］ |
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS［J］. Eur Heart J, 2016,37（38）:2893⁃2962. doi: 10.1093/eurheartj/ehw210.
|
| ［12］ |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines［J］. Circulation, 2021,143（5）:e35⁃e71. doi: 10.1161/CIR.0000000000000932.
|
| ［13］ |
Douketis JD, Foster GA, Crowther MA, et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy［J］. Arch Intern Med, 2000,160（22）:3431⁃3436. doi: 10.1001/archinte.160.22.3431.
|
| ［14］ |
Cabezas⁃Calderon V, Bassas Freixas P, García⁃Patos Briones V. Direct⁃acting oral anticoagulants in dermatologic surgery［J］. Actas Dermosifiliogr（Engl Ed）, 2020,111（5）:357⁃363. doi: 10.1016/j.ad.2019.10.002.
|
| ［15］ |
Siscos SM, Neill BC, Singh AH, et al. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery［J］. J Am Acad Dermatol, 2021,84（2）:425⁃431. doi: 10. 1016/j.jaad.2020.10.008.
|
| ［16］ |
Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient⁃level network meta⁃analyses of randomized clinical trials with interaction testing by age and sex［J］. Circulation, 2022,145（4）:242⁃255. doi: 10.1161/CIRCULATIONAHA.121.056355.
|
| ［17］ |
Kubo K, Kato M, Mabe K, et al. Risk factors for delayed bleeding after therapeutic gastrointestinal endoscopy in patients receiving oral anticoagulants: a multicenter retrospective study［J］. Digestion, 2021,102（2）:161⁃169. doi: 10.1159/000502952.
|
| ［18］ |
Squizzato A, Poli D, Barcellona D, et al. Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies（FCSA） position paper［J］. Thromb Haemost, 2022,122（3）:329⁃335. doi: 10.1055/a⁃1715⁃5960.
|
| ［19］ |
D′Anna L, Filippidis FT, Harvey K, et al. Ischemic stroke in oral anticoagulated patients with atrial fibrillation［J］. Acta Neurol Scand, 2022,145（3）:288⁃296. doi: 10.1111/ane.13552.
|
| ［20］ |
Ito T, Akamatsu K, Hasegawa H, et al. Relationship of warfarin versus DOACs with thrombogenic milieu in the left atrium among patients with nonvalvular atrial fibrillation［J］. Echocardiography, 2022,39（3）:483⁃489. doi: 10.1111/echo.15319.
|
| ［21］ |
Kishore K, Hariprasad SM, Mungee S. Perioperative antiplatelet agents and anticoagulants in vitreoretinal surgery［J］. Ophthalmic Surg Lasers Imaging Retina, 2022,53（2）:71⁃78. doi: 10.3928/23258160⁃20220128⁃01.
|
| ［22］ |
Goryo Y, Kume T, Okamoto H, et al. Influence of dual antiplatelet therapy duration on neointimal condition after second⁃generation drug⁃eluting stent implantation［J］. Cardiovasc Interv Ther, 2022,37（1）:101⁃108. doi: 10.1007/s12928⁃021⁃00765⁃8.
|
| ［23］ |
Harino T, Noura S, Hamabe A, et al. Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery［J］. Surg Endosc, 2022,36（9）:6432⁃6438. doi: 10.1007/s00464⁃021⁃08991⁃0.
|
| ［24］ |
Xiang Y, Zhao H, Ding C, et al. The prophylactic use of tirofiban versus oral antiplatelet medications in stent⁃assisted coiling of intracranial aneurysms: a meta⁃analysis［J］. AJNR Am J Neuroradiol, 2021,42（4）:713⁃719. doi: 10.3174/ajnr.A6996.
|
| ［25］ |
Guo YZ, Zhao ZW, Li SM, et al. Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI［J］. Sci Rep, 2021,11（1）:17144. doi: 10.1038/s41598⁃021⁃96606⁃y.
|
| ［26］ |
Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents［J］. J Am Coll Cardiol, 2007,49（22）:2145⁃2150. doi: 10.1016/j.jacc.2007.02.046.
|
